These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12533273)

  • 1. Novel approaches to preventing chemotherapy-induced cognitive dysfunction in breast cancer: the art of the possible.
    Barton D; Loprinzi C
    Clin Breast Cancer; 2002 Dec; 3 Suppl 3():S121-7. PubMed ID: 12533273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer chemotherapy-related cognitive dysfunction.
    Ahles TA; Saykin AJ
    Clin Breast Cancer; 2002 Dec; 3 Suppl 3():S84-90. PubMed ID: 12533268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of epoetin alfa on cognitive function, mood, asthenia, and quality of life in women with breast cancer undergoing adjuvant chemotherapy.
    O'Shaughnessy JA
    Clin Breast Cancer; 2002 Dec; 3 Suppl 3():S116-20. PubMed ID: 12533272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive dysfunction and chemotherapy: neuropsychological findings in perspective.
    Schagen SB; Muller MJ; Boogerd W; Van Dam FS
    Clin Breast Cancer; 2002 Dec; 3 Suppl 3():S100-8. PubMed ID: 12533270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing cognitive dysfunction in breast cancer: what are the tools?
    Freeman JR; Broshek DK
    Clin Breast Cancer; 2002 Dec; 3 Suppl 3():S91-9. PubMed ID: 12533269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between chemotherapy use and cognitive impairments in older women with breast cancer: findings from a large population-based cohort.
    Du XL; Xia R; Hardy D
    Am J Clin Oncol; 2010 Dec; 33(6):533-43. PubMed ID: 20023570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of adjuvant therapy for breast cancer on cognitive function: current evidence and directions for research.
    Rugo HS; Ahles T
    Semin Oncol; 2003 Dec; 30(6):749-62. PubMed ID: 14663776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
    Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA
    Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive decline.
    Daviglus ML; Bell CC; Berrettini W; Bowen PE; Connolly ES; Cox NJ; Dunbar-Jacob JM; Granieri EC; Hunt G; McGarry K; Patel D; Potosky AL; Sanders-Bush E; Silberberg D; Trevisan M
    NIH Consens State Sci Statements; 2010 Apr; 27(4):1-30. PubMed ID: 20445638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Chemobrain' in breast carcinoma?: a prologue.
    Wefel JS; Lenzi R; Theriault R; Buzdar AU; Cruickshank S; Meyers CA
    Cancer; 2004 Aug; 101(3):466-75. PubMed ID: 15274059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.
    Falleti MG; Sanfilippo A; Maruff P; Weih L; Phillips KA
    Brain Cogn; 2005 Oct; 59(1):60-70. PubMed ID: 15975700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of high-dose and conventional-dose adjuvant chemotherapy on long-term cognitive sequelae in patients with breast cancer: an electrophysiologic study.
    Kreukels BP; Schagen SB; Ridderinkhof KR; Boogerd W; Hamburger HL; Muller MJ; van Dam FS
    Clin Breast Cancer; 2006 Apr; 7(1):67-78. PubMed ID: 16764746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.
    Schagen SB; van Dam FS; Muller MJ; Boogerd W; Lindeboom J; Bruning PF
    Cancer; 1999 Feb; 85(3):640-50. PubMed ID: 10091737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive dysfunction following adjuvant chemotherapy for breast cancer: two case studies.
    Paraska K; Bender CM
    Oncol Nurs Forum; 2003; 30(3):473-8. PubMed ID: 12719746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma. Results of a prospective, randomized, longitudinal trial.
    Maruff P; Falleti MG; Collie A
    Cancer; 2004 Nov; 101(9):2143-4; author reply 2144-5. PubMed ID: 15382092
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study.
    Shilling V; Jenkins V; Morris R; Deutsch G; Bloomfield D
    Breast; 2005 Apr; 14(2):142-50. PubMed ID: 15767184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive side-effects of adjuvant treatments.
    Burstein HJ
    Breast; 2007 Dec; 16 Suppl 2():S166-8. PubMed ID: 17719225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients--evaluation of appropriate research design and methodology to measure symptoms.
    Matsuda T; Takayama T; Tashiro M; Nakamura Y; Ohashi Y; Shimozuma K
    Breast Cancer; 2005; 12(4):279-87. PubMed ID: 16286908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy.
    Lawrence JA; Griffin L; Balcueva EP; Groteluschen DL; Samuel TA; Lesser GJ; Naughton MJ; Case LD; Shaw EG; Rapp SR
    J Cancer Surviv; 2016 Feb; 10(1):176-84. PubMed ID: 26130292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.